An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus

NCT00875108 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biodel